CAS 924377-85-5

GSK1702934A

CAS : 924377-85-5

GSK1702934A

Degré de pureté : ≥98%

Masse moléculaire : 395.52g/mol

Ref: 54-BUP21847

GSK 1702934a

CAS : 924377-85-5

GSK 1702934A is a highly selective antagonist, which is derived from GlaxoSmithKline's series of research compounds targeting specific neuronal pathways. It primarily functions by inhibiting the activity of orexin receptors, particularly orexin 1 receptor (OX1R). This selective antagonism allows for precise modulation of the orexinergic system, which is pivotal in regulating various physiological processes such as sleep-wake cycles, appetite, and stress response.

Formule : C₂₂H₂₅N₃O₂S

Degré de pureté : Min. 95%

Masse moléculaire : 395.5 g/mol

Ref: 3D-ZLB37785

GSK1702934A

CAS : 924377-85-5

GSK1702934A is a TRPC3 agonist with pro-arrhythmic and positive inotropic effects and is used in the study of diabetes mellitus.

Formule : C₂₂H₂₅N₃O₂S

Degré de pureté : 98.15%

Couleur et forme : Solid

Masse moléculaire : 395.52

Ref: TM-T15425